These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 20119467)

  • 1. A tale of two drug testing technologies: GC-MS and LC-MS/MS.
    Mikel C; Pesce A; West C
    Pain Physician; 2010; 13(1):91-2. PubMed ID: 20119467
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of clonazepam compliance by measurement of urinary concentration by immunoassay and LC-MS/MS in pain management population.
    West R; Pesce A; West C; Crews B; Mikel C; Almazan P; Rosenthal M; Latyshev S
    Pain Physician; 2010; 13(1):71-8. PubMed ID: 20119465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protocol for accuracy of point of care (POC) or in-office urine drug testing (immunoassay) in chronic pain patients: a prospective analysis of immunoassay and liquid chromatography tandem mass spectometry (LC/MS/MS).
    Manchikanti L; Malla Y; Wargo BW; Cash KA; Pampati V; Damron KS; McManus CD; Brandon DE
    Pain Physician; 2010; 13(1):E1-E22. PubMed ID: 20119473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of ONTRAK TESTCUP, abuscreen ONTRAK, abuscreen ONLINE, and GC/MS urinalysis test results.
    Crouch DJ; Cheever ML; Andrenyak DM; Kuntz DJ; Loughmiller DL
    J Forensic Sci; 1998 Jan; 43(1):35-40. PubMed ID: 9456522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [False positive screening for drugs of abuse].
    Watine J
    Ann Biol Clin (Paris); 2003; 61(3):367-8. PubMed ID: 12825552
    [No Abstract]   [Full Text] [Related]  

  • 6. Mechanism of interferences for gas chromatography/mass spectrometry analysis of urine for drugs of abuse.
    Wu AH
    Ann Clin Lab Sci; 1995; 25(4):319-29. PubMed ID: 7668815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary screening for methylphenidate (Ritalin) abuse: a comparison of liquid chromatography-tandem mass spectrometry, gas chromatography-mass spectrometry, and immunoassay methods.
    Eichhorst J; Etter M; Lepage J; Lehotay DC
    Clin Biochem; 2004 Mar; 37(3):175-83. PubMed ID: 14972638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of amphetamine, methamphetamine, 3,4-methylenedioxyamphetamine, 3,4-methylenedioxyethylamphetamine, and 3,4-methylenedioxymethamphetamine in urine by online solid-phase extraction and ion-pairing liquid chromatography with detection by electrospray tandem mass spectrometry.
    Wu TY; Fuh MR
    Rapid Commun Mass Spectrom; 2005; 19(6):775-80. PubMed ID: 15712289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative evaluation of the accuracy of benzodiazepine testing in chronic pain patients utilizing immunoassay with liquid chromatography tandem mass spectrometry (LC/MS/MS) of urine drug testing.
    Manchikanti L; Malla Y; Wargo BW; Fellows B
    Pain Physician; 2011; 14(3):259-70. PubMed ID: 21587329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A proficiency test for hair analysis in detecting drug abuse as an index of the quality of toxicologic analysis].
    Rojek S; Kłys M; Scisłowski M
    Arch Med Sadowej Kryminol; 2005; 55(3):195-205. PubMed ID: 16320768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Benefits of Direct-to-Definitive Testing for Monitoring Compliance in Pain Management.
    Gencheva R; Petrides A; Kantartjis M; Tanasijevic M; Dahlin JL; Melanson S
    Pain Physician; 2018 Nov; 21(6):E583-E592. PubMed ID: 30508989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance characteristics of the Cozart RapiScan Oral Fluid Drug Testing System for opiates in comparison to ELISA and GC/MS following controlled codeine administration.
    Kacinko SL; Barnes AJ; Kim I; Moolchan ET; Wilson L; Cooper GA; Reid C; Baldwin D; Hand CW; Huestis MA
    Forensic Sci Int; 2004 Apr; 141(1):41-8. PubMed ID: 15066713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Interpretation of Urine Drug Tests: What Clinicians Need to Know About Urine Drug Screens.
    Moeller KE; Kissack JC; Atayee RS; Lee KC
    Mayo Clin Proc; 2017 May; 92(5):774-796. PubMed ID: 28325505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Power of Orbitrap-based LC-high resolution-MS/MS for comprehensive drug testing in urine with or without conjugate cleavage or using dried urine spots after on-spot cleavage in comparison to established LC-MS
    Michely JA; Meyer MR; Maurer HH
    Drug Test Anal; 2018 Jan; 10(1):158-163. PubMed ID: 28755512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of thin-layer chromatography methods for laxative detection.
    Duncan A; Phillips IJ
    Ann Clin Biochem; 2001 Jan; 38(Pt 1):64-6. PubMed ID: 11270846
    [No Abstract]   [Full Text] [Related]  

  • 16. Rapid screening of drugs of abuse and their metabolites by gas chromatography/mass spectrometry: application to urinalysis.
    Strano-Rossi S; Molaioni F; Rossi F; Botrè F
    Rapid Commun Mass Spectrom; 2005; 19(11):1529-35. PubMed ID: 15880665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug testing.
    Cowan DA
    Essays Biochem; 2008; 44():139-48. PubMed ID: 18384288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two-step silylation procedure for the unified analysis of 190 doping control substances in human urine samples by GC-MS.
    Kiousi P; Angelis YS; Lyris E; Koupparis M; Calokerinos AC; Atta-Politou J; Georgakopoulos CG
    Bioanalysis; 2009 Oct; 1(7):1209-24. PubMed ID: 21083047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of Xipamide metabolite in human urine by high-performance liquid chromatography/diode-array detection, high-performance liquid chromatography/electrospray ionization mass spectrometry and gas chromatography/mass spectrometry.
    Kim Y; Han K; Paeng KJ
    Rapid Commun Mass Spectrom; 2004; 18(20):2505-12. PubMed ID: 15384135
    [No Abstract]   [Full Text] [Related]  

  • 20. A high-throughput urinalysis of abused drugs based on a SPE-LC-MS/MS method coupled with an in-house developed post-analysis data treatment system.
    Cheng WC; Yau TS; Wong MK; Chan LP; Mok VK
    Forensic Sci Int; 2006 Oct; 162(1-3):95-107. PubMed ID: 16876358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.